Biden Administration National Drug Control Policy
Rahul Gupta, director of the White House Office of National Drug Control Policy, took part in a Washington Post virtual discussion on the sy… read more
Rahul Gupta, director of the White House Office of National Drug Control Policy, took part in a Washington Post virtual discussion on the synthetic opioid fentanyl and the Biden administration’s efforts to decriminalize marijuana possession. Topics included drug trafficking, addiction treatment, and inequities in the health care system. close
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and tap the screen to see the at the bottom of the player. Tap the to see a complete list of all Points of Interest - click on any moment in the list and the video will play.
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and move your cursor over the video to see the . Click on the marker to see the description and watch.
You can also click the in the lower left of the video player to see a complete list of all Points of Interest from this program - click on any moment in the list and the video will play.
People in this video
Hosting Organization
Related Video
-
Director of National Drug Control Policy Testifies on 2022 Strategy
Dr. Rahul Gupta, the director of the Office of National Drug Control Policy (ONDCP), testified before the Senate Caucus …
-
Senator Joe Manchin and Health Policy Makers on Combating Opioids
Senator Joe Manchin (D-WV); former Surgeon General Jerome Adams; Dr. Rahul Gupta, the director of National Drug Control …
-
Weekly Presidential Address
In his weekly address, President Trump talked about prescription drug addiction and the opioid epidemic.
-
Combatting the Opioid Epidemic
This program looks at the opioid epidemic. It includes portions of events C-SPAN has covered in 2018, including the Nati…